Logo image of GL9.I

GLANBIA PLC (GL9.I) Stock Fundamental Analysis

DUB:GL9 - Euronext Dublin - IE0000669501 - Common Stock - Currency: EUR

10.14  -0.09 (-0.88%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GL9. GL9 was compared to 57 industry peers in the Food Products industry. GL9 has an average financial health and profitability rating. GL9 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

GL9 had positive earnings in the past year.
In the past year GL9 had a positive cash flow from operations.
In the past 5 years GL9 has always been profitable.
GL9 had a positive operating cash flow in each of the past 5 years.
GL9.I Yearly Net Income VS EBIT VS OCF VS FCFGL9.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

GL9's Return On Assets of 4.25% is fine compared to the rest of the industry. GL9 outperforms 60.34% of its industry peers.
Looking at the Return On Equity, with a value of 7.95%, GL9 is in line with its industry, outperforming 48.28% of the companies in the same industry.
GL9's Return On Invested Capital of 10.62% is amongst the best of the industry. GL9 outperforms 93.10% of its industry peers.
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROIC 10.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GL9.I Yearly ROA, ROE, ROICGL9.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

GL9 has a Profit Margin (4.29%) which is in line with its industry peers.
In the last couple of years the Profit Margin of GL9 has declined.
GL9's Operating Margin of 10.29% is fine compared to the rest of the industry. GL9 outperforms 62.07% of its industry peers.
In the last couple of years the Operating Margin of GL9 has grown nicely.
GL9's Gross Margin of 30.35% is on the low side compared to the rest of the industry. GL9 is outperformed by 65.52% of its industry peers.
In the last couple of years the Gross Margin of GL9 has grown nicely.
Industry RankSector Rank
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
GL9.I Yearly Profit, Operating, Gross MarginsGL9.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GL9 is still creating some value.
There is no outstanding debt for GL9. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GL9.I Yearly Shares OutstandingGL9.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
GL9.I Yearly Total Debt VS Total AssetsGL9.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.11 indicates that GL9 is not in any danger for bankruptcy at the moment.
The Altman-Z score of GL9 (3.11) is better than 79.31% of its industry peers.
The Debt to FCF ratio of GL9 is 2.69, which is a good value as it means it would take GL9, 2.69 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.69, GL9 belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
GL9 has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GL9 (0.45) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Altman-Z 3.11
ROIC/WACC1.45
WACC7.35%
GL9.I Yearly LT Debt VS Equity VS FCFGL9.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

GL9 has a Current Ratio of 1.41. This is a normal value and indicates that GL9 is financially healthy and should not expect problems in meeting its short term obligations.
GL9 has a Current ratio (1.41) which is in line with its industry peers.
A Quick Ratio of 0.81 indicates that GL9 may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, GL9 is in line with its industry, outperforming 43.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.81
GL9.I Yearly Current Assets VS Current LiabilitesGL9.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

4

3. Growth

3.1 Past

GL9 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.61%.
The Earnings Per Share has been growing slightly by 0.50% on average over the past years.
GL9 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.23%.
GL9 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y0.5%
EPS Q2Q%-85.84%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%

3.2 Future

Based on estimates for the next years, GL9 will show a small growth in Earnings Per Share. The EPS will grow by 4.37% on average per year.
GL9 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.90% yearly.
EPS Next Y3.46%
EPS Next 2Y6.58%
EPS Next 3Y4.37%
EPS Next 5YN/A
Revenue Next Year1.47%
Revenue Next 2Y2.34%
Revenue Next 3Y2.25%
Revenue Next 5Y10.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GL9.I Yearly Revenue VS EstimatesGL9.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
GL9.I Yearly EPS VS EstimatesGL9.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.79 indicates a rather expensive valuation of GL9.
The rest of the industry has a similar Price/Earnings ratio as GL9.
GL9 is valuated rather cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.62, the valuation of GL9 can be described as very cheap.
81.03% of the companies in the same industry are more expensive than GL9, based on the Price/Forward Earnings ratio.
GL9's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 17.79
Fwd PE 7.62
GL9.I Price Earnings VS Forward Price EarningsGL9.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

GL9's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GL9 is cheaper than 72.41% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GL9 is valued cheaper than 81.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.94
EV/EBITDA 5.57
GL9.I Per share dataGL9.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GL9 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.15
PEG (5Y)35.77
EPS Next 2Y6.58%
EPS Next 3Y4.37%

3

5. Dividend

5.1 Amount

GL9 has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of GL9 has falen by -26.79%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.35, GL9 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, GL9 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

On average, the dividend of GL9 grows each year by 33.32%, which is quite nice.
Dividend Growth(5Y)33.32%
Div Incr Years6
Div Non Decr Years6
GL9.I Yearly Dividends per shareGL9.I Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

63.39% of the earnings are spent on dividend by GL9. This is not a sustainable payout ratio.
The dividend of GL9 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP63.39%
EPS Next 2Y6.58%
EPS Next 3Y4.37%
GL9.I Yearly Income VS Free CF VS DividendGL9.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GL9.I Dividend Payout.GL9.I Dividend Payout, showing the Payout Ratio.GL9.I Dividend Payout.PayoutRetained Earnings

GLANBIA PLC

DUB:GL9 (3/7/2025, 7:00:00 PM)

10.14

-0.09 (-0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)08-12 2025-08-12
Inst Owners22.41%
Inst Owner ChangeN/A
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap2.60B
Analysts80
Price Target17.62 (73.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.33
Dividend Growth(5Y)33.32%
DP63.39%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.21%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.01%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.36%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE 17.79
Fwd PE 7.62
P/S 0.74
P/FCF 7.94
P/OCF 6.38
P/B 1.36
P/tB 6.08
EV/EBITDA 5.57
EPS(TTM)0.57
EY5.62%
EPS(NY)1.33
Fwd EY13.12%
FCF(TTM)1.28
FCFY12.6%
OCF(TTM)1.59
OCFY15.68%
SpS13.77
BVpS7.43
TBVpS1.67
PEG (NY)5.15
PEG (5Y)35.77
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROCE 14.01%
ROIC 10.62%
ROICexc 12.26%
ROICexgc 30.25%
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
FCFM 9.27%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Debt/EBITDA 1.7
Cap/Depr 55.76%
Cap/Sales 2.27%
Interest Coverage 12.62
Cash Conversion 80.39%
Profit Quality 216.21%
Current Ratio 1.41
Quick Ratio 0.81
Altman-Z 3.11
F-Score6
WACC7.35%
ROIC/WACC1.45
Cap/Depr(3y)51.28%
Cap/Depr(5y)53.27%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.68%
Profit Quality(3y)136.16%
Profit Quality(5y)132.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y0.5%
EPS Q2Q%-85.84%
EPS Next Y3.46%
EPS Next 2Y6.58%
EPS Next 3Y4.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%
Revenue Next Year1.47%
Revenue Next 2Y2.34%
Revenue Next 3Y2.25%
Revenue Next 5Y10.9%
EBIT growth 1Y15.59%
EBIT growth 3Y19.97%
EBIT growth 5Y12.85%
EBIT Next Year36.56%
EBIT Next 3Y13.41%
EBIT Next 5Y8.19%
FCF growth 1Y0.56%
FCF growth 3Y21.96%
FCF growth 5Y21.96%
OCF growth 1Y3.48%
OCF growth 3Y16.3%
OCF growth 5Y16.3%